Author:
Matzuka Brett,Chittenden Jason,Monteleone Jonathan,Tran Hien
Funder
National Science Foundation
National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Aarons L (1999) Pharmacokinetic and pharmacodynamic modelling in drug development. Stat Methods Med Res 8(3):181–182
2. Buse J, DeFronzo RA, Kim T, Skare S, Baron A, Fineman M (2013) Dissociation between metformin plasma exposure and its glucose-lowering effect: a novel gut-mediated mechanism for action. Presentation at the 49th Annual European Association for the Study of Diabetes Meeting, Barcelona, Spain
3. Chi EM, Reinsel GC (1989) Models for longitudinal data with random effects and AR(1) errors. J Am Stat Assoc 84:452–459
4. Davidian M, Giltinan DM (1993) Some general estimation methods for nonlinear mixed-effects model. J Biopharm Stat 3(1):23–55
5. Duong JK, Kumar SS, Kirkpatrick CM, Greenup LC, Arora M, Lee TC, Timmins P, Graham GG, Furlong TJ, Greenfield JR, Williams KM, Day RO (2013) Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin Pharmacokinet 53:373–384
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献